Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow

Similar documents
Cerebrovascular Disease

Cerebrovascular Disease

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

CEREBROVASCULAR DISEASES. By: Shifaa AlQa qa

CEREBRO VASCULAR ACCIDENTS

5. Headache. and/or neck trauma. attributed to moderate. head injury. Glasgow Coma Scale x/15. ICHD II- Chaps 5&6 Posttraumatic and Vascular Headaches

CNS VASCULAR DISEASE. Reid R. Heffner, M.D. Department of Pathology/Anatomy UB Jacobs School of Medicine January 15, 2019

Blood Supply. Allen Chung, class of 2013

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

CNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 7: Non traumatic brain haemorrhage

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

HYPERTENSIVE ENCEPHALOPATHY

IV. Cerebrovascular diseases

Cerebral Vascular Diseases. Nabila Hamdi MD, PhD

Cerebrovascular diseases-2

PTA 106 Unit 1 Lecture 3

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

What is the appropriate evaluation of cryptogenic stroke, and when is a hypercoagulability work-up needed? David E. Thaler, MD, PhD, FAHA

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

CMS Limitations Guide - Radiology Services

Vasculitides in Surgical Neuropathology Practice

Vascular Disorders. Nervous System Disorders (Part B-1) Module 8 -Chapter 14. Cerebrovascular disease S/S 1/9/2013

CEREBROVASCULAR DISEASES. By: Shifaa AlQa qa

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

Neurosurgical Management of Stroke

Disclosures/Conflicts

Stroke Prevention. For more information about stroke, call University Hospital s Heart Line at 706/ or toll free at 866/

11/2/2016. Stroke. Carl F. McComas, M.D. November 3, Disclosures. None (of any kind)

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

UPSTATE Comprehensive Stroke Center. Neurosurgical Interventions Satish Krishnamurthy MD, MCh

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

Atlas of the Vasculitic Syndromes

Single Seizure of Unknown Cause

Stroke/TIA. Tom Bedwell

Cardiovascular Pathology

What Are We Going to Do? Fourth Year Meds Clinical Neuroanatomy. Hydrocephalus and Effects of Interruption of CSF Flow. Tube Blockage Doctrine

Vascular Dementia. Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center

Marc Norman, Ph.D. - Do Not Use without Permission 1. Cerebrovascular Accidents. Marc Norman, Ph.D. Department of Psychiatry

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

Cardiovascular Disease

a. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)).

Nicolas Bianchi M.D. May 15th, 2012

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

Hypertensive Haemorrhagic Stroke. Dr Philip Lam Thuon Mine

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

ISCHEMIC STROKE IMAGING

Alan Barber. Professor of Clinical Neurology University of Auckland

CT INTERPRETATION COURSE

Vasculitis local: systemic

Identifying Cerebrovascular Disorders. Wengui Yu, MD, PhD Department of Neurology, University of California, Irvine

Index. C Capillary telangiectasia, intracerebral hemorrhage in, 295 Carbon monoxide, formation of, in intracerebral hemorrhage, edema due to,

Moyamoya Syndrome with contra lateral DACA aneurysm: First Case report with review of literature

Ischemic Stroke in Critically Ill Patients with Malignancy

Pre-Hospital Stroke Care: Bringing It To The Street. by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center

E X P L A I N I N G STROKE

Recombinant Factor VIIa for Intracerebral Hemorrhage

Cryptogenic Strokes: Evaluation and Management

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

Neuro Quiz 29 Transcranial Doppler Monitoring

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine

SUBSPECIALTY CERTIFICATION EXAMINATION IN VASCULAR NEUROLOGY Content Blueprint (December 8, 2017)

FAQ Identifying and enrolling participants

An Introduc+on to Stroke

Overview of imaging modalities for cerebral aneurysms

ST - segment Elevation Myocardial Infarction complicating an atypical Kawasaki disease

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

Various Stroke and Symptoms and Causes

DIFFERENT STROKES FOR DIFFERENT FOLKS!!

M555 Medical Neuroscience Blood Flow in CNS Meninges Blood Brain Barrier CSF

HPI Signs and Symptoms Considerations

VASCULITIS. Case Presentation. Case Presentation

North Oaks Trauma Symposium Friday, November 3, 2017

Vascular Cognitive Impairment-- NEUROPATHOLOGIC ISSUES. VCI vs. IVD/DEMENTIA with VASCULAR DISEASE (IVD) advanced pathology

Classification and WHO ICD-10NA Codes

Vascular Malformations of the Brain. William A. Cox, M.D. Forensic Pathologist/Neuropathologist. September 8, 2014

PAEDIATRIC VASCULITIS

Vascular pathology. dr. Budiana Tanurahardja.,SpPA

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Blood and Circulation Module Year 3 Semester 1

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

10/19/12. Uncommon Causes of Stroke. José Biller, MD, FACP, FAAN, FAHA Disclosures. Dr. Biller has no disclosures to report

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD

Subclavian artery Stenting

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis

Content. Polyarteritis nodosa. Vasculitis. Giant cell arteritis. Primary cerebral angiitis. Other autoimmune CNS disease.

Strokes in young adults are relatively uncommon;

Comparison of Five Major Recent Endovascular Treatment Trials

Neuropathology autopsy practice: Post-mortem examination in cerebrovascular disease (stroke) DRAFT November 2011

How to Evaluate Patients with Cryptogenic Stroke

InterQual Level of Care 2018 Index

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Supplement Table 1. Definitions for Causes of Death

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

Vasculitis local: systemic

Practical Considerations in the Early Treatment of Acute Stroke

The NIHSS score is 4 (considering 2 pts for the ataxia involving upper and lower limbs.

ENROLLMENT : Line of Business Summary

Transcription:

Neuropathology lecture series III. Neuropathology of Cerebrovascular Disease Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output: 15-20% Percentage of O 2 consumption (resting): 15% Distribution of circulation: anterior circulation > posterior circulation (70%) (30%) gray matter > white matter December 14, 2004 Relatively constant blood flow primarily governed by autoregulatory mechanism Blood flow is a fanction of: perfusion pressure resistance of vascular bed as modified by: arterial pressure pco 2, ph, and oxygen intracranial pressure blood viscosity neurotransmitters??? HIP TRUNK ARM HAND FACE Striatum: Lenticulostriate arteries from MCA(mostly) & ACA Globus Pallidus: Ant. choroidal arteries from ICA Thalamus & Hippocampus: PCA LEG 1

Boundery zone (watershed) Epidemiology of stroke American Heart Association: USA - almost 4 million stroke survivors - almost 730,000 new strokes occur per year Overall age adjusted incidence rates: 100 to 300 / 100,000 Overall, stroke accounts for about 10% of all deaths in most industrialized countries. Most of these deaths are among persons over the age of 65. Average age-adjusted stroke mortality in US: 50 to 100/100,000 Stroke Cerebrovascular accident Brain attack Defined as an abrupt onset of focal or global neurological symptoms caused by ischemia or hemorrhage. By convention, symptoms must continue for >24 hours and is usually associated with permanent damage to brain tissue. If symptoms resolve within 24 hours the episode is called a transient ischemic attack - TIA. Frequencies of stroke subtypes Cerebral infarction 60-80% Intracerebral hemorrhage 10-30% Subarachnoid hemorrhage 5-10% Other (unspecified) 3-25% Determinants of stroke Nonmodifiable risk factors Age Gender Ethnicity Heredity Modifiable risk factors Hypertension Diabetes Cardiac disease (atrial fibrillation) Hypercholesterolemia Cigarette smoking Alcohol abuse Physical inactivity 2

Annual risk of stroke (all subtypes combined) Age group (years) Approximate population risk 0-14 1 in 100,000 15-24 1 in 20,000 25-34 1 in 10,000 35-44 1 in 5,000 45-54 1 in 1,000 55-64 1 in 300 65-74 1 in 100 75-85 1 in 50 >85 1 in 33 Cerebral infarction Morphologic Evolution Sequence of microscopic changes in brain infarcts > 1 hour Microvacuoles within neurons (swollen mitochondria) Perineuronal vacuolation (swollen astrocytic processes) Sequence of microscopic changes in brain infarcts > 1 hour Microvacuoles within neurons (swollen mitochondria) Perineuronal vacuolation (swollen astrocytic processes) 4-12 hours Neuronal cytoplasmic eosinophilia Disappearance of Nissl bodies Pyknotic nuclei Leakage of blood-brain barrier Sequence of microscopic changes in brain infarcts > 1 hour Microvacuoles within neurons (swollen mitochondria) Perineuronal vacuolation (swollen astrocytic processes) 4-12 hours Neuronal cytoplasmic eosinophilia Disappearance of Nissl bodies Pyknotic nuclei Leakage of blood-brain barrier 15-24 hours Neutrophil infiltration begins Sequence of microscopic changes in brain infarcts > 1 hour Microvacuoles within neurons (swollen mitochondria) Perineuronal vacuolation (swollen astrocytic processes) 4-12 hours Neuronal cytoplasmic eosinophilia Disappearance of Nissl bodies Pyknotic nuclei Leakage of blood-brain barrier 15-24 hours Neutrophil infiltration begins 2-3 days Macrophages (foam cells) appear 5 days Neutrophilic infiltration ceases ~ 1 week Proliferation of astrocytes around core infarct 3

Sequence of microscopic changes in brain infarcts > 1 hour Microvacuoles within neurons (swollen mitochondria) Perineuronal vacuolation (swollen astrocytic processes) 4-12 hours Neuronal cytoplasmic eosinophilia Disappearance of Nissl bodies Pyknotic nuclei Leakage of blood-brain barrier 15-24 hours Neutrophil infiltration begins 2-3 days Macrophages (foam cells) appear 5 days Neutrophilic infiltration ceases ~ 1 week Proliferation of astrocytes around core infarct Topographic features size & extent of infarct Site of occlusion Presence/absence of anastomosis Ophthalmic artery (EC-IC) The circle of Willis Leptomeningial anastomosis Underlying conditions of infarction I. Atherosclerosis 4

5

Underlying conditions of infarction II. Arteriolar sclerosis (small artery disease) aging sustained systemic hypertension diabetes mellitus Underlying conditions of infarction III. Cerebral embolism 6

Some causes of cerebral embolism Large or small emboli: atrial fibrillation myocardial infarction bacterial endocarditis rheumatic endocarditis nonbacterial endocarditis cardiac surgery arterial thrombosis Small emboli: ulcerated atheroma trauma (fat emboli) Underlying conditions of infarction IV. Vasculitis/vasculitides 7

Inflammatory CNS vascular diseases Non-infectious vasculitides Primary cranial and/or cerebral inflammations Takayasu s arteritis giant cell or temporal arteritis primary angiitis of the CNS (granulomatous angiitis) Manifestations of systemic diseases systemic lupus erythematosus polyarteritis nodosa Wegener s granulomatosis Churg-Strauss syndrome Behcet s syndrome malignancy related Drug induced vasculitis Infectious vasculitis Cerebral hemorrhage intracerebral subarachnoid epidural /subdural (trauma) Intracerebral hemorrhage Incidence: Caucasian populations - 16-32 / 100,000 Asians > African Americans > Caucasians Causes of non-traumatic ICH: hypertension 50% cerebral amyloid angiopathy 12% anticoagulants 10% tumors 8% illicit and licit drugs 6% arteriovenous malformations and aneurysms 5% miscellaneous 9% Cerebral hemorrhage I. Hypertensive hemorrhage 8

Cerebral hemorrhage II. SAH subarachnodial hemorrhage Frequency: 5-9% of all strokes Reported annual incidence: 10-11 / 100,000 Non-traumatic conditions rupture of aneurysm* 80% arteriovenous malformations** 5-10% unidentified cause 10-15% Secondary intracerebral hemorrhage intraventricular hemorrhage Traumatic 9

Underlying conditions of SAH 1. Intracranial (saccular) aneurysms Frequency at autopsy: 1 to 6% Age at autopsy: 30-70 yrs Sex ratio: F:M = 3:2 Associated hypertension: 50% Familial: Rare Location: Anterior circulation > 80% Posterior circulation < 20% Multiple: 20% Ruptured aneurysms: Size > 0.5 cm Mortality: 60% Underlying conditions of SAH/IPH 2. Vascular malformations 10

Arteriovenous malformations Clinical onset: Age 10 to 40 Sex ratio: M:F = 2:1 Location: Usually supratentorial Clinical presentation: Headache, seizures, focal neurologic deficit, hemorrhage Angiography: Evidence of arteriovenous shunt and abnormal blood vessels Mortality after hemorrhage: 20% 11

Genetics and Stroke Genetic cardiovascular disorders leading to thromboemboli in CNS Arterial dissection, Cardiomyopathies, Neuromuscular diseases, Metabolic conditions (e.g. Homocysteinuria, Coagulopathies, Dyslipidaemia) Genetic metabolic disorders prone to obstruct CNS vessels (e.g. Fabry s disease) CADASIL (AD arteriopathy with subcortical infarcts and leukoencephalopathy) notch 3 MELAS (Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) mitochondrial DNA mutations 12